Journal of International Oncology ›› 2020, Vol. 47 ›› Issue (10): 611-614.doi: 10.3760/cma.j.cn371439-20200311-00087
• Reviews • Previous Articles Next Articles
Liao Chengcheng1, An Jiaxing2, Tan Zhangxue1, Wang Qian3(), Liu Jianguo1,3()
Received:
2020-03-11
Revised:
2020-04-27
Online:
2020-10-08
Published:
2020-11-20
Contact:
Wang Qian,Liu Jianguo
E-mail:qianwang07@126.com;jgl_zmu@126.com
Supported by:
Liao Chengcheng, An Jiaxing, Tan Zhangxue, Wang Qian, Liu Jianguo. Role of FAM3 gene family in tumor[J]. Journal of International Oncology, 2020, 47(10): 611-614.
[1] |
Zhang X, Yang W, Wang J, et al. FAM3 gene family: a promising therapeutical target for NAFLD and type 2 diabetes[J]. Metabolism, 2018,81:71-82. DOI: 10.1016/j.metabol.2017.12.001.
pmid: 29221790 |
[2] |
Tanasova M, Begoyan VV, Weselinski LJ. Targeting sugar uptake and metabolism for cancer identification and therapy: an overview[J]. Curr Top Med Chem, 2018,18(6):467-483. DOI: 10.2174/1568026618666180523110837.
pmid: 29788891 |
[3] |
Cao Y. Adipocyte and lipid metabolism in cancer drug resistance[J]. J Clin Invest, 2019,129(8):3006-3017. DOI: 10.1172/JCI127201.
pmid: 31264969 |
[4] |
Wang H, Yu F, Zhang Z, et al. Effects of circulating member B of the family with sequence similarity 3 on the risk of developing metabolic syndrome and its components:a 5-year prospective study[J]. J Diabetes Investig, 2018,9(4):782-788. DOI: 10.1111/jdi.12780.
pmid: 29178453 |
[5] |
Xiang R, Chen J, Li S, et al. VSMC-specific deletion of FAM3A attenuated angⅡ-promoted hypertension and cardiovascular hypertrophy[J]. Circ Res, 2020, In press. DOI: 10.1161/CIRCRESAHA.119.315558.
doi: 10.1161/CIRCRESAHA.120.317045 pmid: 33107387 |
[6] |
Xu W, Liang M, Zhang Y, et al. Endothelial FAM3A positively regulates post-ischaemic angiogenesis[J]. EBioMedicine, 2019,43:32-42. DOI: 10.1016/j.ebiom.2019.03.038.
pmid: 31000420 |
[7] |
Chaudhury A, Hussey GS, Ray PS, et al. TGF-β-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translatio-nal induction of Dab2 and ILEI[J]. Nat Cell Biol, 2010,12(3):286-293. DOI: 10.1038/ncb2029.
doi: 10.1038/ncb2029 pmid: 20154680 |
[8] |
Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma[J]. Gastroenterology, 2018,154(2):360-373. DOI: 10.1053/j.gastro.2017.08.023.
pmid: 28823862 |
[9] |
Zhu YH, Zhang B, Li M, et al. Prognostic significance of FAM3C in esophageal squamous cell carcinoma[J]. Diagn Pathol, 2015,10:192. DOI: 10.1186/s13000-015-0424-8.
doi: 10.1186/s13000-015-0424-8 |
[10] | Jin LL, Zhang SJ, Lu GX, et al. miR-574-3p inhibits proliferation and invasion in esophageal cancer by targeting FAM3C and MAPK1[J]. Kaohsiung J Med Sci, 2020,36(5):318-327. DOI: 10.1002/kjm2.12176. |
[11] | He SL, Wang WP, Yang YS, et al. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition[J]. J Cell Mol Med, 2019,23(2):1375-1385. DOI: 10.1111/jcmm14040. |
[12] |
Song WM, Lin X, Liao X, et al. Multiscale network analysis reveals molecular mechanisms and key regulators of the tumor microenvironment in gastric cancer[J]. Int J Cancer, 2020,146(5):1268-1280. DOI: 10.1002/ijc.32643.
doi: 10.1002/ijc.32643 pmid: 31463974 |
[13] | 李海军, 王孟薇, 吴本俨, 等. FAM3B基因cDNA克隆及其在胃癌细胞系BGC-823的表达[J]. 中国药物与临床, 2007,7(12):896-898. DOI: 10.3969/j.issn.1671-2560.2007.12.002. |
[14] |
Shi M, Duan G, Nie S, et al. Elevated FAM3C promotes cell epithelial-mesenchymal transition and cell migration in gastric cancer[J]. Onco Targets Ther, 2018,11:8491-8505. DOI: 10.2147/OTT.S178455.
doi: 10.2147/OTT.S178455 pmid: 30584315 |
[15] |
Ahmed M. Colon cancer: a clinician's perspective in 2019[J]. Gastroenterology Res, 2020,13(1):1-10. DOI: 10.14740/gr1239.
pmid: 32095167 |
[16] |
Li Z, Mou H, Wang T, et al. A non-secretory form of FAM3B promotes invasion and metastasis of human colon cancer cells by upregulating Slug expression[J]. Cancer Lett, 2013,328(2):278-284. DOI: 10.1016/j.canlet.2012.09.026.
doi: 10.1016/j.canlet.2012.09.026 pmid: 23059759 |
[17] | 万晓晨, 马小红, 程璐, 等. FAM3C蛋白与结肠癌临床病理相关性[J]. 肿瘤学杂志, 2017,23(5):413-416. DOI: 10.11735/j.issn.1671-170X.2017.05.B011. |
[18] |
Gao ZH, Lu C, Wang ZN, et al. ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer[J]. Histopathology, 2014,65(4):527-538. DOI: 10.1111/his.12435.
pmid: 24738665 |
[19] |
Solmi R, De Sanctis P, Zucchini C, et al. Search for epithelial-specific mRNAs in peripheral blood of patients with colon cancer by RT-PCR[J]. INT J Oncol, 2004,25(4):1049-1056.
pmid: 15375555 |
[20] |
Llach J, Carballal S, Moreira L. Familial pancreatic cancer: current perspectives[J]. Cancer Manag Res, 2020,12:743-758. DOI: 10.2147/CMAR.S172421.
doi: 10.2147/CMAR.S172421 pmid: 32099470 |
[21] | Gronborg M, Kristiansen TZ, Iwahori A, et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach[J]. Mol Cell Proteomics, 2006,5(1):157-171. DOI: 10.1074/mcp.M500178-MCP200. |
[22] | Souza JJS, Machado MCC, Fortes MAHZ, et al. Cytokine-like FAM3D gene is associated to diabetes mellitus in pancreatic adenocarcinoma[J]. Pancreas, 2006,33(4):498. DOI: 10.1097/00006676-200611000-00208. |
[23] | Holt JD, Gerayli F. Prostate cancer screening[J]. Prim Care, 2019,46(2):257-263. DOI: 10.1016/j.pop.2019.02.007. |
[24] |
Maciel-Silva P, Caldeira I, de Assis Santos I, et al. FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-XL cell survival genes[J]. BMC Cancer, 2018,18(1):90. DOI: 10.1186/s12885-017-3950-9.
pmid: 29357840 |
[25] | Sun Y, Jia X, Gao Q, et al. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI)[J]. IUBMB Life, 2017,69(1):16-21. DOI: 10.1002/iub.1585. |
[26] |
La Rosa GRM, Gattuso G, Pedullà E, et al. Association of oral dysbiosis with oral cancer development[J]. Oncol Lett, 2020,19(4):3045-3058. DOI: 10.3892/ol.2020.11441.
doi: 10.3892/ol.2020.11441 pmid: 32211076 |
[27] | Wu CC, Xiao Y, Li H, et al. Overexpression of FAM3C is associa-ted with poor prognosis in oral squamous cell carcinoma[J]. Pathol Res Pract, 2019,215(4):772-778. DOI: 10.1016/j.prp.2019.01.019. |
[28] | 迟毓婧, 李玫, 禹祎萌, 等. FAM3C通过激活Akt促进口腔鳞癌细胞活力[J]. 中国病理生理杂志, 2019,35(3):424-429. DOI: 10.3969/j.issn.1000-4718.2019.03.007. |
[29] | De Cicco P, Catani MV, Gasperi V, et al. Nutrition and breast cancer: a literature review on prevention, treatment and recurrence[J]. Nutrients, 2019,11(7):1514. DOI: 10.3390/nu11071514. |
[30] |
Woosley AN, Dalton AC, Hussey GS, et al. TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis[J]. Oncogene, 2019,38(20):3794-3811. DOI: 10.1038/s41388-019-0703-z.
doi: 10.1038/s41388-019-0703-z pmid: 30692635 |
[31] |
Yang W, Feng B, Meng Y, et al. FAM3C-YY1 axis is essential for TGFβ-promoted proliferation and migration of human breast cancer MDA-MB-231 cells via the activation of HSF1[J]. J Cell Mol Med, 2019,23(5):3464-3475. DOI: 10.1111/jcmm.14243.
doi: 10.1111/jcmm.14243 pmid: 30887707 |
[1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[4] | Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349. |
[5] | Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353. |
[6] | Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358. |
[7] | Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363. |
[8] | Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[9] | Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[10] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[11] | Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273. |
[12] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[13] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[14] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291. |
[15] | Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||